Fucidin is a medication containing the active ingredient fusidic acid. It is also known by the names Fucidin H or Fucithalmic, depending on the form. Fucidin is used to treat bacterial skin infections.
The common price range for Fucidin lies between £20.08 – £26.42 per creams. This range is subject to the size of the packaging and the potency of the contained ingredients (1 or 10 gm).
Fucidin contains the active ingredient fusidic acid, a bacteriostatic antibiotic derived from the fungus Fusidium coccineum. Fusidic acid works by inhibiting bacterial protein synthesis, rendering bacteria unable to produce essential proteins required for their growth and multiplication.
Fucidin is commonly indicated for the treatment of skin infections caused by Staphylococcus aureus and other susceptible bacteria. It is used in conditions such as impetigo, infected dermatitis, and infected cuts or abrasions. The topical formulation is effective in treating primary and secondary skin infections.
Fucidin is available in several dosage forms including ointments, creams, and gels for topical application. The specific formulation is chosen based on the type of skin infection and the location on the body. Some formulations may also be available in combination with other active ingredients.
Fusidic acid inhibits bacterial protein synthesis by blocking elongation factor G (EF-G) from binding to the ribosome. This interruption prevents the translation process, stopping bacterial growth and replication while allowing the human immune system to eliminate the remaining bacteria.
Fucidin must be applied directly to the affected area. Before application, clean and dry the skin gently. A thin layer of ointment/cream should be applied 2-3 times daily, or as directed by a healthcare professional. It should be used for the prescribed duration to avoid antibiotic resistance.
Fucidin may interact with other topical products. It is crucial to inform the healthcare provider about all current medications. Simultaneous use of other topical antibiotics should be avoided unless specifically advised. Oral interaction data is limited due to its topical nature.
Fucidin is contraindicated in individuals who have shown hypersensitivity to fusidic acid or any of the components in the formulation. It is also contraindicated in patients with certain types of skin lesions or conditions as determined by a healthcare provider.
Fucidin should not be ingested or applied near the eyes, mouth, or mucous membranes. Special precautions should be taken when used in pregnant or breastfeeding women, and its use should be critically assessed by a healthcare professional in these populations.
Fucidin should be stored in a cool, dry place away from direct sunlight. The container should be tightly closed after each use. Do not freeze. Compliance with storage instructions ensures the medication retains its efficacy and safety.
Handle Fucidin with clean hands to avoid contamination. Dispose of expired or unnecessary medication following local regulations for biomedical waste disposal. Do not flush the medication down the toilet unless instructed to do so.
Fusidic acid has limited systemic absorption when applied topically. However, when absorption occurs, it is highly protein-bound in plasma and metabolized in the liver. The excretion primarily occurs via the biliary system into the faeces.
Common side effects include mild irritation at the site of application, such as itching, burning, or redness. Rarely, it can cause allergic reactions presenting as severe itch, rash, or swelling. Report significant side effects to a healthcare professional immediately.
If a dose of Fucidin is missed, apply it as soon as remembered. However, if it is close to the next scheduled dose, skip the missed dose. Avoid applying extra medication to make up for the missed dose.
Monitor the infection site for signs of improvement or any worsening conditions. Patients should be advised to follow up with their healthcare provider if the infection persists or any adverse effects occur. Regular monitoring ensures the treatment is effective and adjustments can be made if necessary.
Complete the full course of Fucidin even if symptoms improve to avoid bacterial resistance. Stopping treatment early may lead to incomplete eradication of the bacteria and recurrence of the infection. Follow the prescribed duration closely for optimal outcomes.
In the case of topical overdose, excess medication should be removed. Overdose is unlikely due to minimal systemic absorption; however, any unusual symptoms should prompt consultation with a healthcare provider. Records of administration assist in managing and preventing overdose.
Prior to use, conduct an allergy test by applying a small amount of Fucidin to a limited area of skin and observing for any adverse reactions. This precaution is vital for individuals with a history of drug allergies to minimize the risk of severe allergic reactions.
Use Fucidin strictly as prescribed to reduce the risk of bacterial resistance. Overuse or misuse can lead to decreased effectiveness and increased bacterial resistance. Educating patients on proper use is crucial in curbing resistance development.
Studies demonstrate that Fucidin is highly effective against Gram-positive bacteria, particularly Staphylococcus species, often outperforming many other topical antibiotics. Its efficacy provides a reliable treatment option for localized skin infections.
Fucidin can be used in combination with other antibiotics for synergistic effects in managing resistant bacterial infections. Such combinations are directed by healthcare professionals based on clinical assessments and microbial culture results.